BioStem Technologies, Inc. (BSEM) Tops Q3 EPS by 21c

BioStem Technologies, Inc. (OTC: BSEM) reported Q3 EPS of $0.03, $0.21 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
• Midland States Bancorp, Inc. (MSBI) Tops Q2 EPS by 4c
• Glacier Bancorp (GBCI) Tops Q2 EPS by 1c, Misses on Revenue